🚀 VC round data is live in beta, check it out!
EvokAI Valuation Multiples
Discover revenue and EBITDA valuation multiples for EvokAI and similar public comparables like Epigenomics, Chordate Medical Holding, Inhalation Sciences SWE, Remedent and more.
EvokAI Overview
About EvokAI
EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.
Founded
2011
HQ
Employees
10
Website
Sectors
Financials (FY)
EV
$1M
EvokAI Financials
EvokAI reported last fiscal year revenue of — and negative EBITDA of ($17M).
In the same fiscal year, EvokAI generated ($17M) in EBITDA losses and had net loss of ($17M).
EvokAI P&L
In the most recent fiscal year, EvokAI reported revenue of — and EBITDA of ($17M).
EvokAI expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($17M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($17M) | XXX | XXX | XXX |
| Net Debt | — | — | $13K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
EvokAI Stock Performance
EvokAI has current market cap of $643K, and enterprise value of $1M.
Market Cap Evolution
EvokAI's stock price is $0.08.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1M | $643K | (0.2%) | XXX | XXX | XXX | $-2.25 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEvokAI Valuation Multiples
EvokAI trades at (0.1x) EV/EBITDA.
EvokAI Financial Valuation Multiples
As of March 13, 2026, EvokAI has market cap of $643K and EV of $1M.
Equity research analysts estimate EvokAI's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
EvokAI has a P/E ratio of 0.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $643K | XXX | $643K | XXX | XXX | XXX |
| EV (current) | $1M | XXX | $1M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (0.1x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (0.6x) | XXX | XXX | XXX |
| P/E | — | XXX | 0.0x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (0.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified EvokAI Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
EvokAI Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Epigenomics | XXX | XXX | XXX | XXX | XXX | XXX |
| Chordate Medical Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| Inhalation Sciences SWE | XXX | XXX | XXX | XXX | XXX | XXX |
| Remedent | XXX | XXX | XXX | XXX | XXX | XXX |
| Nuwellis | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
EvokAI M&A Activity
EvokAI acquired XXX companies to date.
Last acquisition by EvokAI was on XXXXXXXX, XXXXX. EvokAI acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by EvokAI
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEvokAI Investment Activity
EvokAI invested in XXX companies to date.
EvokAI made its latest investment on XXXXXXXX, XXXXX. EvokAI invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by EvokAI
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout EvokAI
| When was EvokAI founded? | EvokAI was founded in 2011. |
| Where is EvokAI headquartered? | EvokAI is headquartered in Canada. |
| How many employees does EvokAI have? | As of today, EvokAI has over 10 employees. |
| Who is the CEO of EvokAI? | EvokAI's CEO is Alejandro Antalich. |
| Is EvokAI publicly listed? | Yes, EvokAI is a public company listed on Toronto Stock Exchange. |
| What is the stock symbol of EvokAI? | EvokAI trades under OKAI ticker. |
| When did EvokAI go public? | EvokAI went public in 2023. |
| Who are competitors of EvokAI? | EvokAI main competitors are Epigenomics, Chordate Medical Holding, Inhalation Sciences SWE, Remedent. |
| What is the current market cap of EvokAI? | EvokAI's current market cap is $643K. |
| Is EvokAI profitable? | No, EvokAI is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.